Oral anticoagulation in patients with hypertrophic cardiomyopathy and non‐valvular atrial fibrillation in Japan
Abstract Aims There are limited data to support direct oral anticoagulant (DOAC) use in patients with hypertrophic cardiomyopathy (HCM) and non‐valvular atrial fibrillation (NVAF). The current study investigated the safety and effectiveness of DOACs versus warfarin in patients in Japan. Methods This...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2025-02-01
|
| シリーズ: | ESC Heart Failure |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/ehf2.15039 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|